MedMira Unaware of Any Material Change

(firmenpresse) - HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/09/17 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), at the request of IIROC, wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.

About MedMira

MedMira is the developer and owner of Rapid Vertical Flow (RVF) Technologya. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad™ brands in global markets. MedMira's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada and the Company has a sales and customer service office located in the United States. For more information visit . Follow us on and .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain assumptions, estimates, and other forward-looking statements regarding future events. Such forward-looking statements involve inherent risks and uncertainties and are subject to factors, many of which are beyond the Company's control that may cause actual results or performance to differ materially from those currently anticipated in such statements.



Contacts:
MedMira Inc.
Hermes Chan
CEO
902 450 1588


MedMira Inc.
Andrea Young
Corporate Communications
902-450-1588

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 09.03.2017 - 16:37 Uhr
Sprache: Deutsch
News-ID 529305
Anzahl Zeichen: 0

contact information:
Town:

HALIFAX, NOVA SCOTIA

Kategorie:

Medical Devices

Diese Pressemitteilung wurde bisher 240 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MedMira Unaware of Any Material Change"
steht unter der journalistisch-redaktionellen Verantwortung von

MedMira Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

MedMira Receives CE Mark for Syphilis/HIV Multiplex Rapid Test ...

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 05/01/17 -- Editors Note: There is a photo associated with this press release.MedMira Inc. (MedMira) (TSX VENTURE: MIR), a developer of rapid diagnostic technology platforms and testing solutions, has receive ...

MedMira Reports FY2017 Second Quarter Results ...

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/31/17 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), reported today on its financial results for the three and six month periods ending January 31, 2017. The Company recorded steady product sales with incre ...

MedMira Announces AGM Results and Stock Option Grant ...

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 01/30/17 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR) held its 2017 Annual General Meeting of Shareholders on January 27, 2017. Incumbent Directors Mr. Hermes Chan and Mr. Marvyn Robar were re-elected. Dr. Sh ...

Alle Meldungen von MedMira Inc.